These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38498317)

  • 1. The effects of prophylactic use of esketamine on postoperative depression and quality of life: a meta-analysis.
    Niu G; Zheng X; Deng B; Du YS; Mei Y
    Minerva Anestesiol; 2024 Apr; 90(4):321-329. PubMed ID: 38498317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.
    Dean RL; Hurducas C; Hawton K; Spyridi S; Cowen PJ; Hollingsworth S; Marquardt T; Barnes A; Smith R; McShane R; Turner EH; Cipriani A
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD011612. PubMed ID: 34510411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of perioperative ketamine or esketamine on the subjective quality of recovery after surgery: a meta-analysis of randomised controlled trials.
    Hung KC; Kao CL; Ho CN; Hsing CH; Chang YJ; Wang LK; Liao SW; Chen IW
    Br J Anaesth; 2024 Jun; 132(6):1293-1303. PubMed ID: 38614917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of esketamine for perioperative depression in patients undergoing elective surgery: A meta-analysis of randomized controlled trials.
    Lou XJ; Qiu D; Ren ZY; Hashimoto K; Zhang GF; Yang JJ
    Asian J Psychiatr; 2024 May; 95():103997. PubMed ID: 38492442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between esketamine interventions and postpartum depression and analgesia following cesarean delivery: a systematic review and meta-analysis.
    Ma S; Dou Y; Wang W; Wei A; Lan M; Liu J; Yang L; Yang M
    Am J Obstet Gynecol MFM; 2024 Mar; 6(3):101241. PubMed ID: 38262519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of perioperative application of esketamine on postoperative depression: a meta-analysis of randomized controlled studies.
    Wen Y; Mao M; Jiang M; Liu Q; Li Q; Wang X; Yuan H; Wang X; Feng S
    Int J Surg; 2024 Jun; ():. PubMed ID: 38935104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Music therapy for depression.
    Aalbers S; Fusar-Poli L; Freeman RE; Spreen M; Ket JC; Vink AC; Maratos A; Crawford M; Chen XJ; Gold C
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD004517. PubMed ID: 29144545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of perioperative application of esketamine on postpartum depression in cesarean section: A systematic review and meta-analysis.
    Ma B; Tao X; Qi Y; Cao H; Cao Q; Zhou Z; Wang S
    Medicine (Baltimore); 2024 Jul; 103(27):e38821. PubMed ID: 38968456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer.
    Cramer H; Lauche R; Klose P; Lange S; Langhorst J; Dobos GJ
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010802. PubMed ID: 28045199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.
    Bahji A; Vazquez GH; Zarate CA
    J Affect Disord; 2021 Jan; 278():542-555. PubMed ID: 33022440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Esterman AJ; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012347. PubMed ID: 30838649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intraoperative and/or postoperative esketamine administration on preventing postpartum depression: A systematic review and meta-analysis.
    Wang J; Liu H; Wei X
    Psychiatry Res; 2024 May; 335():115890. PubMed ID: 38579458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial interventions for preventing and treating depression in dialysis patients.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis of the efficacy of ketamine and esketamine on suicidal ideation in treatment-resistant depression.
    Wang YT; Wang XL; Lei L; Guo ZY; Kan FF; Hu D; Gai C; Zhang Y
    Eur J Clin Pharmacol; 2024 Feb; 80(2):287-296. PubMed ID: 38117332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Music interventions for improving psychological and physical outcomes in people with cancer.
    Bradt J; Dileo C; Myers-Coffman K; Biondo J
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD006911. PubMed ID: 34637527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mindfulness-based stress reduction for women diagnosed with breast cancer.
    Schell LK; Monsef I; Wöckel A; Skoetz N
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011518. PubMed ID: 30916356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses.
    Lima TM; Visacri MB; Aguiar PM
    Eur J Clin Pharmacol; 2022 Mar; 78(3):311-338. PubMed ID: 34705064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse Effects of Esketamine for the Treatment of Major Depression Disorder: Findings from Randomized Controlled Trials.
    Yang S; Wang J; Li X; Wang T; Xu Z; Xu X; Zhou X; Chen G
    Psychiatr Q; 2022 Mar; 93(1):81-95. PubMed ID: 33411126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.